PlainRecalls
FDA Drug Moderate Class II Terminated

Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.

Reported: January 27, 2016 Initiated: November 4, 2015 #D-0581-2016

Product Description

Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.

Reason for Recall

Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.

Details

Recalling Firm
Pine Pharmaceuticals, LLC
Units Affected
N/A
Distribution
Nationwide and Puerto Rico
Location
Tonawanda, NY

Frequently Asked Questions

What product was recalled?
Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.. Recalled by Pine Pharmaceuticals, LLC. Units affected: N/A.
Why was this product recalled?
Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 27, 2016. Severity: Moderate. Recall number: D-0581-2016.